Skip to content
Riskpilot
← Back to search
Sign in
Get full access
C.K. Biotech AB
AB
Active
Org 5569232571
Orrspelsvägen 33, 167 66
Bromma
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2013
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
C.K. Biotech AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−8
−3
−14
−2
−2
Depreciation & amort.
−0
−5
−5
−5
−0
EBIT
−8
−8
−19
−7
−2
Net financials
35
—
—
—
—
Profit before tax
28
−8
−19
−7
−2
Tax
−6
−0
−0
−0
−0
Net profit
22
−8
−19
−7
−2
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
143
136
117
110
108
Equity
138
136
117
110
108
Long-term debt
0
0
0
0
0
Short-term debt
6
0
0
0
0
Total debt
6
—
—
—
—
Financial ratios
5-year trend
EBITDA margin
-200000.0%
This company
15.8%
Market median
-1265923% vs market
2021
2025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2021
2025
Return on equity
-1.9%
This company
18.4%
Market median
-110% vs market
2021
2025
Net profit margin
-200000.0%
This company
8.1%
Market median
-2469236% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-01-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-02-01 – 2023-01-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-02-01 – 2022-01-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-02-01 – 2021-01-31
View
PDF
More on C.K. Biotech AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
